The CMS has removed the provider review version of a new database that details financial relationships between healthcare providers and drug and medical-device manufacturers.
The CMS has removed the provider review version of a new database that details financial relationships between healthcare providers and drug and medical-device manufacturers.
It's unclear whether pulling the system offline signals that all its Sunshine Act-mandated information about payments to physicians and teaching hospitals from drug and medical-device makers will be publicly available Sept. 30 as originally scheduled.
“We don't know if that means there will be a delay in the launch of the entire website,” said Dr. Daniel Carlat, director of the Prescription Project at the Pew Charitable Trusts. “This seems just like an appropriate part of the CMS' diligence in making sure the website eventually works smoothly and delivers accurate data once it is launched.”
Read the full story here: http://bit.ly/1oCEoHs
Source: Modern Healthcare
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More
President Biden will preview his plan to more than double the size of Medicare’s new drug price negotiation program in the upcoming State of the Union address; Mexicans and Central Americans were most affected by the pandemic in terms of all-cause mortality; two Alabama fertility clinics said they expect to resume in vitro fertilization (IVF) services after a bill was passed to protect doctors.
Read More